ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.90
0.66%
US Tech 100
19,282.40
0.35%
S&P 500
5,482.87
0.09%
US Dollar vs CAD
1.36985
-0.05%
Bitcoin
61,442.90
1.04%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Imunon Inc (IMNN)

  7. Imunon Inc (IMNN) News

IMNN

Imunon (IMNN)

Imunon Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMNN
DateTimeSourceHeadlineSymbolCompany
06/24/20247:30AMGlobeNewswire Inc.IMUNON Announces Database Lock for Phase 2 OVATION 2 Study with IMNN-001 in Advanced Ovarian CancerNASDAQ:IMNNImunon Inc
06/14/20245:15AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:13AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:11AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:09AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:08AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:06AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/14/20245:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/13/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
06/10/20241:00PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
06/05/20247:30AMGlobeNewswire Inc.First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical TrialNASDAQ:IMNNImunon Inc
05/22/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMNNImunon Inc
05/20/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
05/15/20243:16PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IMNNImunon Inc
05/15/20247:30AMGlobeNewswire Inc.Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual MeetingNASDAQ:IMNNImunon Inc
05/14/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNNImunon Inc
05/13/20248:00AMGlobeNewswire Inc.IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine StudyNASDAQ:IMNNImunon Inc
05/13/20247:10AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMNNImunon Inc
05/13/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
05/13/20247:00AMGlobeNewswire Inc.IMUNON Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IMNNImunon Inc
05/08/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
05/08/20247:00AMGlobeNewswire Inc.IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEONASDAQ:IMNNImunon Inc
05/06/202410:00AMGlobeNewswire Inc.IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024NASDAQ:IMNNImunon Inc
04/18/20247:30AMGlobeNewswire Inc.IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101NASDAQ:IMNNImunon Inc
04/11/20247:00AMGlobeNewswire Inc.IMUNON Reports Compliance with Nasdaq Listing RequirementsNASDAQ:IMNNImunon Inc
03/28/20247:00AMGlobeNewswire Inc.IMUNON Reports 2023 Financial Results and Provides Business UpdateNASDAQ:IMNNImunon Inc
03/25/20247:30AMGlobeNewswire Inc.IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating LossesNASDAQ:IMNNImunon Inc
03/21/20244:00PMGlobeNewswire Inc.IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024NASDAQ:IMNNImunon Inc
03/13/20247:00AMGlobeNewswire Inc.IMUNON Files IND Application to Begin Human Testing of IMNN-101NASDAQ:IMNNImunon Inc
03/12/20244:00PMGlobeNewswire Inc.IMUNON Announces Leadership ChangeNASDAQ:IMNNImunon Inc
 Showing the most relevant articles for your search:NASDAQ:IMNN

Your Recent History

BIT
UC8FRE
Unicredit Bank
BIT
UC45YW
Unicredit Bank
BIT
UB4QB8
Unicredit Bank
USOTC
RSBQS
RSE Archive (GM)
BIT
P21TJ0
NLBNPIT21TJ0 20351221 4....
LSE
46OB
Perm Mast 58 S
USOTC
FIRRF
First Tractor (PK)
LSE
51RQ
Natwest Grp 25
BIT
I09245
Intesa Sanpaolo
TSXV
VCT
Volt Carbon Technologies
TSX
MMX
Maverix Metals
BIT
UB30DQ
UniCredit Bank
LSE
II93
Barclays 29
TSXV
SPI
Canadian Spirit Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved